Fulgent Genetics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Fulgent Genetics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $322.67 million for the year ending 2025.

  • Fulgent Genetics, Inc. showed an increase of +13.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from Fulgent Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Fulgent Genetics, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 1,622.7%.
  • Historical annual values: Fiscal year 2025: $322.67 million | Fiscal year 2024: $283.47 million | Fiscal year 2023: $289.21 million | Fiscal year 2022: $618.97 million | Fiscal year 2021: $992.58 million | Fiscal year 2020: $421.71 million | Fiscal year 2019: $32.53 million | Fiscal year 2018: $21.35 million | Fiscal year 2017: $18.73 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: